|Therapeutic Uses||used alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) to trea|
|Directions for Use||as per doctor prescription|
|Minimum Order Quantity||5 Bottle|
Venetoclax is used alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) to treat certain types of chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) or certain types of small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes).
There are no reviews for this product.